2020 Poster Session - Annual Meeting of the New England Consortium of Metabolic Programs
ABSTRACTS ACCEPTED FOR ORAL PRESENTATION:
1) The pheNIX Trial: the First-In-Human Gene Therapy Trial for PKU due to Phenylalanine Hydroxylase (PAH) Deficiency
Author(s): Bodamer O
Affiliations: Division of Genetics and Genomics, Boston Children’s Hospital and Broad Institute of Harvard University and MIT
2) For the Health of Their Children: PKU Caregiver Study
Author(s): Bolduc DeFilippo J
Affiliations: Instructor, Salem State University School of Social Work and PhD Student, Simmons University School of Social Work
Poster #1
Read Abstract here.
Poster #2
Read Abstract here.
